药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Magnesium salicylate
Nimesulide
The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Nimesulide.
Magnesium salicylate
Ertugliflozin
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Polyethylene glycol.
Magnesium salicylate
Potassium
The risk or severity of adverse effects can be increased when Potassium is combined with Polyethylene glycol.
Magnesium salicylate
Bromotheophylline
The risk or severity of adverse effects can be increased when Bromotheophylline is combined with Polyethylene glycol.
Magnesium salicylate
Epitizide
The risk or severity of adverse effects can be increased when Epitizide is combined with Polyethylene glycol.
Magnesium salicylate
Xipamide
The risk or severity of adverse effects can be increased when Xipamide is combined with Polyethylene glycol.
Magnesium salicylate
Muzolimine
The risk or severity of adverse effects can be increased when Muzolimine is combined with Polyethylene glycol.
Magnesium salicylate
Clopamide
The risk or severity of adverse effects can be increased when Clopamide is combined with Polyethylene glycol.
Magnesium salicylate
Fenquizone
The risk or severity of adverse effects can be increased when Fenquizone is combined with Polyethylene glycol.
Magnesium salicylate
Clofenamide
The risk or severity of adverse effects can be increased when Clofenamide is combined with Polyethylene glycol.
Magnesium salicylate
Clorexolone
The risk or severity of adverse effects can be increased when Clorexolone is combined with Polyethylene glycol.
Magnesium salicylate
Cyclopenthiazide
The risk or severity of adverse effects can be increased when Cyclopenthiazide is combined with Polyethylene glycol.
Magnesium salicylate
Mebutizide
The risk or severity of adverse effects can be increased when Mebutizide is combined with Polyethylene glycol.
Magnesium salicylate
Mefruside
The risk or severity of adverse effects can be increased when Mefruside is combined with Polyethylene glycol.
Magnesium salicylate
Meticrane
The risk or severity of adverse effects can be increased when Meticrane is combined with Polyethylene glycol.
Magnesium salicylate
Cicletanine
The risk or severity of adverse effects can be increased when Cicletanine is combined with Polyethylene glycol.
Magnesium salicylate
Spiradoline
The risk or severity of adverse effects can be increased when Spiradoline is combined with Polyethylene glycol.
Magnesium salicylate
Rolofylline
The risk or severity of adverse effects can be increased when Rolofylline is combined with Polyethylene glycol.
Magnesium salicylate
Canrenone
The risk or severity of adverse effects can be increased when Canrenone is combined with Polyethylene glycol.
Magnesium salicylate
Isosorbide
The risk or severity of adverse effects can be increased when Isosorbide is combined with Polyethylene glycol.